NF
GILD icon

Norwood Financial’s Gilead Sciences GILD Stock Holding History

Norwood Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$177K Buy
2,415
+1,690
+233% +$130K 0.26% 76
2023
Q4 		$58.7K Sell
725
-15
-2% -$1.17K 0.09% 144
2023
Q3 		$55.5K Hold
740
– – 0.09% 139
2023
Q2 		$57K Hold
740
– – 0.09% 142
2023
Q1 		$61.4K Hold
740
– – 0.1% 130
2022
Q4 		$63.5K Hold
740
– – 0.1% 121
2022
Q3 		$46K Hold
740
– – 0.08% 135
2022
Q2 		$46K Hold
740
– – 0.08% 132
2022
Q1 		$44K Sell
740
-20
-3% -$1.28K 0.06% 147
2021
Q4 		$55K Buy
+760
New +$52.3K 0.08% 135

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norwood Financial's GILD Position: Q1 2024 in Review

Norwood Financial increased its Gilead Sciences (GILD) stake by 233% in Q1 2024, buying an estimated $130K and bringing the position to 2,415 shares worth $177K. The position accounts for 0.26% of the portfolio, ranked #76.

Norwood Financial first reported a position in GILD in Q4 2021 and has held it in 10 quarters since. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Norwood Financial held 2,415 shares of Gilead Sciences worth $177K as of Q1 2024.
  • Norwood Financial bought 1,690 Gilead Sciences shares in Q1 2024, an estimated $130K.
  • Gilead Sciences made up 0.26% of Norwood Financial's portfolio in Q1 2024, its #76 holding.
  • Norwood Financial first reported a position in Gilead Sciences in Q4 2021 and has held it in 10 quarters since.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.